HOME >> BIOLOGY >> NEWS
Light-activated compound silences nerves, may one day help epileptics

March 5, 2007 -- Brain activity has been compared to a light bulb turning on in the head. Scientists at Washington University School of Medicine in St. Louis have reversed this notion, creating a drug that stops brain activity when a light shines on it.

The unexpected result, reported online in Nature Neuroscience, turned several lights on in researchers' heads.

"This is daydreaming at this point, but we might one day combine this drug with a small implanted light to stop seizures," says senior author Steven Mennerick, Ph.D. associate professor of psychiatry and of anatomy and neurobiology. "Some current experimental epilepsy treatments involve the implanting of an electrode, so why not a light?"

The new compound activates the same receptor used by many anesthetics and tranquilizers, making it harder for a brain cell to respond to stimulation. Mennerick and colleagues including lead author Larry Eisenman, M.D., Ph.D., assistant professor of neurology, tested the drug on cells in culture set up to behave like they were involved in a seizure, with the cells rapidly and repeatedly firing. When they added the new drug and shone a light on the cells, the seizure-like firing pattern calmed.

If the drug is adapted for epilepsy, Mennerick notes, it is most likely to help in cases where seizures consistently originate from the same brain region. Theoretically, doctors could keep a patient on regular doses of the new drug and implant a small fiber optic light in the dysfunctional region. The light would activate the drug only when seizure-like firing patterns started to appear.

Scientists in the laboratory of Douglas F. Covey, Ph.D., professor of molecular biology and pharmacology, created the drug by linking a steroid known to have anesthetic effects with a molecule, known as NBD, that fluoresces in response to blue light. Mennerick and colleagues were hoping to use the new compound, which they call the NBD-steroid, to trace the steroid's pat
'"/>

Contact: Michael C. Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
6-Mar-2007


Page: 1 2 3

Related biology news :

1. Light-activated therapy targets DNA components
2. A compound from olive-pomace oil gets 80 percent slowing down of HIV spread
3. New compound effectively treats fungal infections
4. Natural compound and exercise boost memory in mice
5. Lipoic acid explored as anti-aging compound
6. Pharmaceutical compounds found in nations fresh water
7. Chinese medicinal compound stops formation of cysts in polycystic kidney disease in lab
8. EPA selects Phylonix to screen compound library in zebrafish
9. Anti-wrinkle compound causes pathological reaction in skin cells
10. Marine moss reveals clues to anticancer compound
11. New compound prevents alcoholic behavior, relapse in animals by blocking stress response

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 17, 2019 , ... Georgia ... pediatric urologists are among the professionals honored in U.S. News & World ... the country’s pediatric healthcare landscape. , Georgia Urology’s wholly-owned subsidiary, Georgia ...
(Date:7/10/2019)... ... 10, 2019 , ... Inference Solutions , a global ... announced its role in Pizza Hut Australia’s digital transformation initiative to ... key part of this initiative is implementation of an automated call-steering application that ...
(Date:6/27/2019)... ... ... Lighting designers from integrated design firm LPA recently earned two ... both engaging and energy efficient lighting systems. , The lighting for the repositioning of ... California earned an IES Illumination Award of Merit in the Energy and Environment category. ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff has been named ... as the 2019 Innovative Product of the Year which highlights cutting-edge advancements and ... Sensors Expo & Conference 2019, held this week in San Jose, ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/11/2019)... ... 2019 , ... Thought Technology Ltd is pleased to announce ... Tech Ltd as its authorised distributor for the UK and Ireland. , ... and clinical assessment protocols to treat stress related disorders as well as provide ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Carilion Clinic, a national leader in opioid treatment, announced today they are partnering ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic ...
Breaking Biology Technology:
Cached News: